Publication: Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.
No Thumbnail Available
Identifiers
Date
2018-07-02
Authors
Stahl, Maximilian
DeVeaux, Michelle
Montesinos, Pau
Itzykson, Raphaël
Ritchie, Ellen K
Sekeres, Mikkael A
Barnard, John
Podoltsev, Nikolai A
Brunner, Andrew
Komrokji, Rami S
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Description
MeSH Terms
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Drug Resistance, Neoplasm
Female
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Retrospective Studies
Risk Assessment
Risk Factors
Survival Analysis
Transplantation, Homologous
Treatment Outcome
Young Adult
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Drug Resistance, Neoplasm
Female
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Retrospective Studies
Risk Assessment
Risk Factors
Survival Analysis
Transplantation, Homologous
Treatment Outcome
Young Adult